The global metagenomic sequencing market involves sequencing the DNA isolated directly from environmental samples containing complex microbial communities without isolating or culturing individual microbial species. Metagenomic sequencing helps reveal microbial diversity in diverse environments and their functional capacities. This innovative technique provides insights into microbial community structure and functions, helps determine the genetic potential of microbial communities present across a wide variety of environments including human body sites, soil, oceans and more.

The Global Metagenomic Sequencing Market Size Is Estimated To Be Valued At US$ 1.41 Bn In 2024 And Is Expected To Exhibit A CAGR Of 17.% Over The Forecast Period From 2024-2031.

Key Takeaways

Key players operating in the global metagenomic sequencing market Are Illumina, QIAGEN, Thermo Fisher Scientific, Oxford Nanopore Technologies, BGI Group, Perkinelmer, GENEWIZ, Macrogen, Zymo Research, Diversigen, Microsynth AG, Baseclear, MR DNA (Molecular Research), Eurofins Scientific, Novogene Corporation, Nugen Technologies, Takara Bio, Swift Biosciences, New England Biolabs, And Cosmosid. These key players are focusing on new product launches and strengthening their global distribution networks to expand their market share.

The growing demand for disease diagnosis is fueling the growth of the global metagenomic sequencing market. Metagenomic sequencing helps in identification of unknown microbial pathogens, enables comprehensive pathogen detection from clinical samples and aids in disease diagnosis. It is increasingly being used to study various human diseases including cystic fibrosis, inflammatory bowel disease, cancer and more.

The global metagenomic sequencing market is witnessing significant expansion across regions. Factors such as increasing R&D investments, growing focus on microbiome therapeutics development and rising adoption of metagenomics for environmental and industrial applications are supporting the market growth globally. The market is experiencing high growth in Asia Pacific region driven by increasing healthcare spending, rising focus on precision medicine in countries like China and India.

Market Drivers

One of the key drivers for the global metagenomic sequencing market is increasing application of metagenomics in drug discovery. Metagenomic approaches aid in identification of novel biosynthetic gene clusters encoding for bioactive natural products, which can be further developed as new drugs. Additionally, metagenomics helps reveal microbial diversity in diverse environments which opens up new opportunities for discovery of microbes and bioactive molecules that have potential to be developed into new therapies. This expanding application of metagenomics in drug discovery is expected to propel the market growth over the forecast period.

Impact of geopolitical situation on market growth and geographical regions
The current geopolitical turmoil has significantly impacted the growth of the global metagenomic sequencing market. The rising geopolitical tensions between major countries has disrupted global supply chains and international collaborations for R&D activities. This has hampered the easy cross-border exchange of sequencing reagents, consumables and other critical supplies needed for metagenomic research projects. It has also disrupted international scientific conferences and collaboration initiatives that serve as platforms for discovery and innovations using metagenomics approaches. Addressing such geopolitical challenges would require strategic efforts to enhance local manufacturing capacities, establish alternative regional supply networks, and facilitate virtual interactions among scientific communities globally. Looking ahead, fostering more geopolitically resilient international frameworks for scientific cooperation and open innovation would be important to sustain the long-term growth momentum of this market.

North America has traditionally been the most lucrative region for the metagenomic sequencing market in terms of value, driven by extensive R&D investments and a flourishing biotechnology industry in the US and Canada. However, Asia Pacific is emerging as the fastest growing regional market propelled by the rising governmental focus on genomics and biomedical research in China, India, Japan, South Korea and other countries. Considerable opportunities also exist in the Europe market stimulated by growing pan-European initiatives for metagenomics applications in healthcare, agriculture, bioenergy and environmental surveillance. Meanwhile, developments of local sequencing infrastructure and collaborations with international players could help open up new avenues for market expansion across Latin America, Middle East and Africa over the coming years.

Geographically, the market in North America accounted for the largest revenue share in 2024. This is due to the extensive R&D investments and a flourishing biotechnology industry in the US and Canada. However, the Asia Pacific region is projected to witness the fastest CAGR over the forecast period. The rising focus of governments in China, India, Japan, South Korea, and other countries on genomics and biomedical research is fueling the growth of the metagenomic sequencing market in Asia Pacific. Europe is also expected to offer lucrative opportunities driven by growing pan-European initiatives for metagenomics applications in various end-use industries. Developing local infrastructure and collaborating with international players could help expand the potential for market growth in Latin America, Middle East, and Africa. Overall, stringent regulations, advances in sequencing technologies, and reducing costs are factors expected to aid the market expansion globally.

What are the key data covered in this Global Metagenomic Sequencing Market report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Global Metagenomic Sequencing Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Global Metagenomic Sequencing  Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behavior

:- Global Metagenomic Sequencing  Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Global Metagenomic Sequencing  Market vendors

FAQ’s

Q.1 What are the main factors influencing the Global Metagenomic Sequencing market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Metagenomic Sequencing Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Metagenomic Sequencing market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?

Get more insights on this topic:

https://www.feedsfloor.com/pharmaceuticals/global-metagenomic-sequencing-market-will-grow-highest-pace-owing-increasing